Suppr超能文献

非白喉棒状杆菌临床分离株的鉴定及其抗生素敏感性模式

Identification of clinical isolates of nondiphtherial Corynebacterium species and their antibiotic susceptibility patterns.

作者信息

Williams D Y, Selepak S T, Gill V J

机构信息

Clinical Pathology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

Diagn Microbiol Infect Dis. 1993 Jul;17(1):23-8. doi: 10.1016/0732-8893(93)90065-f.

Abstract

Starting in 1982, our laboratory has performed species identification of coryneform bacteria isolated from blood cultures, intravenous (i.v.) catheter tips and sites, urines with high colony counts, and other potentially significant cultures, using predefined criteria. Of 283 isolates identified, Corynebacterium jeikeium was the most common (47%), followed by CDC group G2 (12%) and C. minutissimum (8%). Blood cultures and i.v. catheter-related sources were the most frequent sources (58% of total). Certain species or groups, like CDC group G2, were most frequently isolated from blood or i.v. catheter sites. CDC group G2 showed a progression to greater multiple antibiotic resistance during this 9-year period. Occasional multiresistant strains of other species were also encountered. By in vitro testing, we note vancomycin remains the most active agent against corynebacterialike organisms, and is the most reliable antibiotic to use while awaiting susceptibility testing results.

摘要

自1982年起,我们的实验室一直依据预定义标准,对从血培养、静脉内(i.v.)导管尖端及部位、高菌落计数尿液以及其他潜在重要培养物中分离出的棒状杆菌进行菌种鉴定。在鉴定出的283株分离菌中,杰氏棒状杆菌最为常见(47%),其次是疾病控制与预防中心(CDC)G2组(12%)和极小棒状杆菌(8%)。血培养和与静脉内导管相关的来源是最常见的来源(占总数的58%)。某些菌种或菌组,如CDC G2组,最常从血液或静脉内导管部位分离得到。在这9年期间,CDC G2组呈现出对多种抗生素耐药性增加的趋势。偶尔也会遇到其他菌种的多重耐药菌株。通过体外试验,我们注意到万古霉素仍然是对抗棒状杆菌样微生物最有效的药物,并且是在等待药敏试验结果期间最可靠的抗生素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验